Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

× No keyword cloud information.

68 in total

Review 1. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review.

Authors: Laura M C Welschen; Evelien Bloemendal; Giel Nijpels; Jacqueline M Dekker; Robert J Heine; Wim A B Stalman; Lex M Bouter
Journal: Diabetes Care Date: 2005-06 Impact factor: 19.112

2. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.

Authors: A Holstein; A Plaschke; E H Egberts
Journal: Diabetes Metab Res Rev Date: 2001 Nov-Dec Impact factor: 4.876

3. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors: Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112

Review 4. Biologic actions and therapeutic potential of the proglucagon-derived peptides.

Authors: Daniel J Drucker
Journal: Nat Clin Pract Endocrinol Metab Date: 2005-11

5. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Authors: Philip Raskin; Elsie Allen; Priscilla Hollander; Andrew Lewin; Robert A Gabbay; Peter Hu; Bruce Bode; Alan Garber
Journal: Diabetes Care Date: 2005-02 Impact factor: 19.112

6. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors: V Fonseca; J Rosenstock; R Patwardhan; A Salzman
Journal: JAMA Date: 2000-04-05 Impact factor: 56.272

7. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

Authors: David M Nathan; John Lachin; Patricia Cleary; Trevor Orchard; David J Brillon; Jye-Yu Backlund; Daniel H O'Leary; Saul Genuth
Journal: N Engl J Med Date: 2003-06-05 Impact factor: 91.245

8. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors: Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal: Diabetes Res Clin Pract Date: 1995-05 Impact factor: 5.602

9. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors: P Reichard; B Y Nilsson; U Rosenqvist
Journal: N Engl J Med Date: 1993-07-29 Impact factor: 91.245

10. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors:
Journal: Diabetes Date: 1995-08 Impact factor: 9.461

91 in total

1. Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.

Authors: J J Nolan
Journal: Diabetologia Date: 2010-04-25 Impact factor: 10.122

Review 2. Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?

Authors: R J Heine; M Diamant; J-C Mbanya; D M Nathan
Journal: BMJ Date: 2006-12-09

3. Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

Authors: D Raccah
Journal: Diabetologia Date: 2007-03-10 Impact factor: 10.122

Review 4. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Authors: André J Scheen
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

5. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors: D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal: Diabetologia Date: 2008-01 Impact factor: 10.122

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.